SCHEMBL4489158

SCHEMBL4489158

CN(C)S(=O)(=O)c1ccc(N2CCc3c(Cl)ncnc32)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 3/20 0.41
CYP2C9 P11712 1/20 0.39
GRIA2 P42262 1/20 0.39
HSD17B10 Q99714 1/20 0.36
MCOLN2 Q8IZK6 1/20 0.36
PTGS2 P35354 2/20 0.36
HTR6 P50406 1/20 0.35
SMN1; SMN2 Q16637 4/20 0.35
ALDH1A1 P00352 2/20 0.35
LMNA P02545 2/20 0.35
HTT P42858 2/20 0.35
CCNA2 P20248 1/20 0.34
CDK2 P24941 1/20 0.34
CCNA1 P78396 1/20 0.34
EGFR P00533 1/20 0.34
ERBB2 P04626 1/20 0.34
TP53 P04637 2/20 0.33
GAA P10253 1/20 0.33
NPC1 O15118 1/20 0.33
MAPK1 P28482 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4492509 0.76 HTT (0.40) GPR119CYP2C9SMN1; SMN2ALDH1A1LMNA
SCHEMBL4489892 0.71 GPR119 (0.83) GPR119CYP2C9
SCHEMBL375962 0.71 GPR119 (0.61) GPR119CYP2C9
SCHEMBL4479394 0.69 CYP1A2 (0.38) GPR119CYP2C9SMN1; SMN2ALDH1A1LMNA
SCHEMBL12546040 0.68 MEN1 (0.44) HTR6SMN1; SMN2ALDH1A1HTTRAB9A
SCHEMBL4491806 0.67 GPR119 (0.37) GPR119SMN1; SMN2ALDH1A1LMNAHTT
SCHEMBL21823166 0.63 HTT (0.44) ALDH1A1LMNAHTTTP53GAA
SCHEMBL4844627 0.62 PTGS2 (0.43) CYP2C9HSD17B10PTGS2SMN1; SMN2ALDH1A1
SCHEMBL10086924 0.62 ALDH1A1 (0.40) SMN1; SMN2ALDH1A1LMNAHTT
SCHEMBL21244024 0.62 LMNA (0.59) HSD17B10SMN1; SMN2ALDH1A1LMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8222261-B2 Chemical compounds GlaxoSmithKline, LLC (US) 2012-07-17 US disclosed
US-20090318477-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE LLC 2009-12-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090318477-A1 CHEMICAL COMPOUNDS GPR119, GOT2, SLC5A2 GPR119 1/4885CYP2C9 971/4885GRIA2 1342/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.